0 Ratings
ID

44389

Description

Efficacy of Fish Oil in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01842191

Link

https://clinicaltrials.gov/show/NCT01842191

Keywords

Versions (2)
  1. 1/18/19 1/18/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Relapsing- Remitting Multiple Sclerosis NCT01842191

    English

    Eligibility Relapsing- Remitting Multiple Sclerosis NCT01842191

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients had clinically definite and magnetic resonance image supported ms
    Description

    Multiple Sclerosis Magnetic Resonance Imaging

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0026769
    UMLS CUI [1,2]
    C0024485
    had at least one relapse in the year before entry into the study
    Description

    Relapse Quantity

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0035020
    UMLS CUI [1,2]
    C1265611
    edss score of 0-5
    Description

    EDSS

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0451246
    treated with subcutaneous 250 μg interferon beta-1b (betaseron, bayer)
    Description

    interferon beta-1b Subcutaneous Dose | Betaseron

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0244713
    UMLS CUI [1,2]
    C1522438
    UMLS CUI [1,3]
    C0178602
    UMLS CUI [2]
    C0284968
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    they were taking another supplement
    Description

    Supplement Other

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0242295
    UMLS CUI [1,2]
    C0205394
    had progressive forms of ms
    Description

    Progressive multiple sclerosis

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0393665
    had history of severe depression
    Description

    Severe depression

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0588008
    had history of acute liver or renal dysfunction
    Description

    Liver Dysfunction | Renal dysfunction

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0086565
    UMLS CUI [2]
    C3279454
    had history of tobacco, drug or alcohol abuse
    Description

    Tobacco Use Disorder | Substance Use Disorders

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0040336
    UMLS CUI [2]
    C0038586
    had intolerance, contraindication or allergy to fish oil
    Description

    Intolerance to Fish Oils | Medical contraindication Fish Oils | Fish oils allergy

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1744706
    UMLS CUI [1,2]
    C0016157
    UMLS CUI [2,1]
    C1301624
    UMLS CUI [2,2]
    C0016157
    UMLS CUI [3]
    C0571871
    Back to the top of the page

    Similar models

    Eligibility Relapsing- Remitting Multiple Sclerosis NCT01842191

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Multiple Sclerosis Magnetic Resonance Imaging
    Item
    patients had clinically definite and magnetic resonance image supported ms
    boolean
    C0026769 (UMLS CUI [1,1])
    C0024485 (UMLS CUI [1,2])
    Relapse Quantity
    Item
    had at least one relapse in the year before entry into the study
    boolean
    C0035020 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    EDSS
    Item
    edss score of 0-5
    boolean
    C0451246 (UMLS CUI [1])
    interferon beta-1b Subcutaneous Dose | Betaseron
    Item
    treated with subcutaneous 250 μg interferon beta-1b (betaseron, bayer)
    boolean
    C0244713 (UMLS CUI [1,1])
    C1522438 (UMLS CUI [1,2])
    C0178602 (UMLS CUI [1,3])
    C0284968 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    Supplement Other
    Item
    they were taking another supplement
    boolean
    C0242295 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    Progressive multiple sclerosis
    Item
    had progressive forms of ms
    boolean
    C0393665 (UMLS CUI [1])
    Severe depression
    Item
    had history of severe depression
    boolean
    C0588008 (UMLS CUI [1])
    Liver Dysfunction | Renal dysfunction
    Item
    had history of acute liver or renal dysfunction
    boolean
    C0086565 (UMLS CUI [1])
    C3279454 (UMLS CUI [2])
    Tobacco Use Disorder | Substance Use Disorders
    Item
    had history of tobacco, drug or alcohol abuse
    boolean
    C0040336 (UMLS CUI [1])
    C0038586 (UMLS CUI [2])
    Intolerance to Fish Oils | Medical contraindication Fish Oils | Fish oils allergy
    Item
    had intolerance, contraindication or allergy to fish oil
    boolean
    C1744706 (UMLS CUI [1,1])
    C0016157 (UMLS CUI [1,2])
    C1301624 (UMLS CUI [2,1])
    C0016157 (UMLS CUI [2,2])
    C0571871 (UMLS CUI [3])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial